SCORED trial：Sotagliflozin Slows CKD Progression in Patients With T2DM
Sotagliflozin Slows CKD Progression in Patients With T2DM
2023年11月16日—Thetrialrevealedthatuseofthedualsodium-glucosecotransporter(SGLT)1and2inhibitorsotagliflozinenhanceskidneyandcardiorenaloutcomesin ...。其他文章還包含有：「SotagliflozininPatientswithDiabetesandChronicKidney...」、「EffectofSotagliflozinonCardiovascularandRenalEvents...」、「SCOREDTrial」、「NCT03315143」、「SotagliflozinandKidneyOutcomes」、「ASecondaryAnalysisoftheSCOREDTrial...
查看更多 離開網站
Sotagliflozin in Patients with Diabetes and Chronic Kidney ...
https://www.nejm.org
We conducted a multicenter, double-blind trial in which patients with type 2 diabetes mellitus (glycated hemoglobin level, ≥7%), chronic kidney ...
Effect of Sotagliflozin on Cardiovascular and Renal Events ...
https://www.acc.org
The SCORED trial showed that sotagliflozin has salutary effects on CV outcomes among patients with T2DM and CKD. Description: The goal of ...
SCORED Trial
https://www.inpefahcp.com
Learn about the SCORED trial in patients with type 2 diabetes mellitus, chronic kidney disease, and cardiovascular risk factors, including a history of ...
NCT03315143
https://clinicaltrials.gov
沒有這個頁面的資訊。
Sotagliflozin and Kidney Outcomes
https://journals.lww.com
SCORED was a multicenter, randomized trial evaluating cardiorenal outcomes with sotagliflozin versus placebo in 10,584 patients with type 2 diabetes and CKD.
A Secondary Analysis of the SCORED Trial
https://pubmed.ncbi.nlm.nih.go
Methods: SCORED was a multicenter, randomized trial evaluating cardiorenal outcomes with sotagliflozin versus placebo in 10,584 patients with ...
Did the SCORED Trial Get Extra Points for Kidney ...
https://journals.lww.com
The two most extensive trials evaluating cardiovascular outcomes in patients receiving sotagliflozin include the SOLOIST-WHF and SCORED trials.